Boado RJ - Search Results

1

Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor.

Coloma MJ, Lee HJ, Kurihara A, Landaw EM, Boado RJ, Morrison SL, Pardridge WM. Coloma MJ, et al. Among authors: boado rj. Pharm Res. 2000 Mar;17(3):266-74. doi: 10.1023/a:1007592720793. Pharm Res. 2000. PMID: 10801214

2

Rat blood-brain barrier genomics. II.

Li JY, Boado RJ, Pardridge WM. Li JY, et al. Among authors: boado rj. J Cereb Blood Flow Metab. 2002 Nov;22(11):1319-26. doi: 10.1097/01.WCB.0000040944.89393.0f. J Cereb Blood Flow Metab. 2002. PMID: 12439289

3

Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes.

Zhang YF, Boado RJ, Pardridge WM. Zhang YF, et al. Among authors: boado rj. Pharm Res. 2003 Nov;20(11):1779-85. doi: 10.1023/b:pham.0000003375.13655.f9. Pharm Res. 2003. PMID: 14661922

4

Developmental regulation of the rabbit blood-brain barrier LAT1 large neutral amino acid transporter mRNA and protein.

Boado RJ, Li JY, Pardridge WM. Boado RJ, et al. Pediatr Res. 2004 Apr;55(4):557-60. doi: 10.1203/01.PDR.0000113461.07950.72. Epub 2004 Feb 5. Pediatr Res. 2004. PMID: 14764922

5

Decline in exogenous gene expression in primate brain following intravenous administration is due to plasmid degradation.

Chu C, Zhang Y, Boado RJ, Pardridge WM. Chu C, et al. Among authors: boado rj. Pharm Res. 2006 Jul;23(7):1586-90. doi: 10.1007/s11095-006-0274-x. Epub 2006 Jun 21. Pharm Res. 2006. PMID: 16779704

6

Lysosomal enzyme replacement of the brain with intravenous non-viral gene transfer.

Zhang Y, Wang Y, Boado RJ, Pardridge WM. Zhang Y, et al. Among authors: boado rj. Pharm Res. 2008 Feb;25(2):400-6. doi: 10.1007/s11095-007-9357-6. Epub 2007 Jun 30. Pharm Res. 2008. PMID: 17602284

7

Intravenous siRNA of brain cancer with receptor targeting and avidin-biotin technology.

Xia CF, Zhang Y, Zhang Y, Boado RJ, Pardridge WM. Xia CF, et al. Among authors: boado rj. Pharm Res. 2007 Dec;24(12):2309-16. doi: 10.1007/s11095-007-9460-8. Epub 2007 Oct 11. Pharm Res. 2007. PMID: 17926121

8

Engineering and expression of a chimeric transferrin receptor monoclonal antibody for blood-brain barrier delivery in the mouse.

Boado RJ, Zhang Y, Wang Y, Pardridge WM. Boado RJ, et al. Biotechnol Bioeng. 2009 Mar 1;102(4):1251-8. doi: 10.1002/bit.22135. Biotechnol Bioeng. 2009. PMID: 18942151 Free PMC article.

9

Antibody-mediated targeting of siRNA via the human insulin receptor using avidin-biotin technology.

Xia CF, Boado RJ, Pardridge WM. Xia CF, et al. Among authors: boado rj. Mol Pharm. 2009 May-Jun;6(3):747-51. doi: 10.1021/mp800194y. Mol Pharm. 2009. PMID: 19093871 Free PMC article.

10

Pharmacokinetics and safety in rhesus monkeys of a monoclonal antibody-GDNF fusion protein for targeted blood-brain barrier delivery.

Pardridge WM, Boado RJ. Pardridge WM, et al. Among authors: boado rj. Pharm Res. 2009 Oct;26(10):2227-36. doi: 10.1007/s11095-009-9939-6. Epub 2009 Jul 17. Pharm Res. 2009. PMID: 19609743 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters